PPARG and type 2 diabetes mellitus: PPAR-γ (peroxisome proliferator-activated receptor gamma) agonists, such as pioglitazone, were initially introduced to treat insulin resistance in type II diabetes mellitus, showing the ability to reduce albuminuria.